Sky-High Costs

By dividing pharmaceutical company's research and development budgets by the number of approved drugs over 15 years, Forbes' Matthew Herper and Scott DeCarlo came up with new estimates of drug development costs. "The range of money spent is stunning," Herper says at his blog.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.